comparemela.com

Latest Breaking News On - Uk azn - Page 1 : comparemela.com

U.K. stocks continue positive streak, climb for second session

U.K. stocks finished higher Friday, with the FTSE 100 Index growing 0.28% at 7,706.28. Among FTSE 100 constituents, major international banks company.

Standard-chartered
Article-normal
Clothing
Banking
Commercial-banking
Banking-credit
Clothing-textiles
Consumer-goods
Financial-services
International-banks
Equity-markets

AstraZeneca Shares Top FTSE 100 Index Risers After Tagrisso Gets U.S. Approval

By Ian Walker AstraZeneca shares are up and leading the FTSE 100 index risers after the company said that its lung-cancer treatment Tagrisso, together with.

United-states
America
Dave-fredrickson
Ian-walker
Astrazeneca
South-america
Article-normal
Biotechnology-services
Pharmaceuticals
Healthcare-life-sciences
Biopharmaceuticals
Cancer

U.K. stocks extend positive streak for fourth day

U.K. stocks increased Monday, as the FTSE 100 Index finished up 0.22% at 7,728.50. Among FTSE 100 constituents, aerospace products/parts company Rolls-Royce.

Royce-holdings
Rolls-royce-holdings
Article-normal
Aerospace-products-parts
Aircraft-engines
Aerospace-defense
Industrial-goods
Financial-performance
Corporate-industrial-news
Equity-markets
Commodity-financial-market-news

U.K. stocks drop Tuesday

U.K. stocks dropped Tuesday, as the FTSE 100 Index closed down 0.81% at 7,512.28. Among FTSE 100 constituents, residential building construction company.

Barratt-developments
Article-normal
Metal-ore-mining
Silver-ore-mining
Building-construction
Residential-building-construction
Banking
Commercial-banking
Basic-materials-resources
Banking-credit
Construction

AstraZeneca Sees Double-Digit Growth for Core Earnings, Revenue in 2024 -- Update

By Elena Vardon AstraZeneca sees its revenue and core earnings per share growing by double-digit percentages in 2024, the pharmaceuticals major said as it.

Sweden
London
City-of
United-kingdom
Swedish
Elena-vardon
Pascal-soriot
Astrazeneca
Executive-pascal-soriot
Article-normal
Biotechnology-services
Pharmaceuticals

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.